This program will address current trends in cannabis securities litigation. Participants can expect to receive information on a variety of cannabis-related securities cases, including the most recent of such cases, which was filed in April 2022. Participants will learn about the current strategies taken in securities actions through cases at varying stages of litigation.
Upon completion of this program, participants should expect to be able to identify common causes of action levied against cannabis-related entities and strategies those entities can implement to mitigate risk.
In this session the panelists will discuss international hemp-derived products trade. More specifically, the panelists will offer an overview of what transatlantic trade of hemp-derived products (food products, cosmetic products, vaping products…) for consumer use looks like with a particular focus on import and export of these products from the US market to the EU and/or the UK market(s) and from the EU and/or the UK to the USA.
In this session the panelist will set the stage by discussing the Agricultural Improvement Act, more commonly known as the Farm Bill; specifically, the watershed moment in 2018 where industrial hemp was provided a federally legal pathway. The panel will discuss the unintended consequences created by the definition and function of weight allowance for delta-9 THC and its application to manufactured hemp derived products. The impacts of the definition on the hemp industry, the regulated marijuana industry and overall public health.
Learn about the hemp-derived Minnesota Model and how it is viewed as a preview to what will happen on the federal level. As goes Minnesota, so goes the rest of the nation? Join local and national speakers for their analysis and predictions, who will also discuss novel/intoxicating hemp-derived cannabinoids and their regulation under both state and federal law, including Delta-8 THC, THC-O, and others.
The panel will focus on the regulations applicable to foodstuff in the US, Mexico, Colombia and Chile. In particular, we will discuss different regulations in connection to dietary supplements, nutraceuticals, advertisement and further challenging issues for the industry, to later focus on the approach that these regulations have regarding the use of hemp in foodstuff products and future challenges in this regard.
The franchise business model offers hemp business owners the opportunity to grow their brand nationally while reducing their startup and operational costs. It offers prospective hemp franchisees the chance to own their own business while benefiting from an established brand and operational system. But a poorly created franchise system or an “accidental” franchise, can expose hemp businesses to the risk of regulatory investigation, litigation, and the loss of key IP such as trademarks and trade secrets. Conflicting state regulations and the lack of significant federal guidance makes franchising a hemp business even more complex.
Cannabis law and policy continue to quickly evolve and the past year has seen major legal developments for the regulated marijuana and hemp industries. Moderated by Paul Demko, Cannabis Editor at POLITICO, this panel of experts bring their broad legal and policy perspectives to identify and comment upon important court rulings and litigation trends, as well as anticipated changes to the law heading into 2024 on a variety of legal topics.
Join our panelists for an honest and supportive discussion about harm reduction, stress management, and mental health among attorneys. Learn how to support colleagues in recovery or who are struggling – and how to recognize and manage these challenges in yourself. Discuss how to make colleagues understand that attorney wellness is not merely a buzzword or a generational difference; it is directly related to competence to practice and meeting duties to clients.
As the cannabis industry grows and more states allow cannabis licensing, the ethical duties that cannabis attorneys must balance have grown more complicated. These ethical duties require lawyers to balance and re-evaluate their duty to zealously advocate for their clients with the duty of candor, their duties to all of their cannabis clients – and, at times, their belief systems and why they entered cannabis law originally. Join our expert panel to discuss these duties and how they try to balance them in their cannabis practices and emerge with a renewed sense of how to identify issues that may challenge competing duties as attorneys and ways to resolve these conflicts.